Navigation Links
GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix

GlaxoSmithKline will supply 8 million doses of its flu vaccine, Fluarix. This dosage is twice the amount GSK shipped to US last year. This amount of 8 million doses only represents about 10% of the demand from the US, due to increased need for vaccines against flu.// The immense need for vaccination increased due to large vaccination awareness programs organized in the US during recent years, due to the protection it offers against Influenza. The US wants the stock ready for the winter to avoid any shortage in supply which occurred last year. US Health authorities as approved the GSK, which is the biggest UK Pharmaceutical company, which supplied flu vaccines to US last year during the shortage of vaccines. Jean-Pierre Garnier, the chief executive of GSK, said: "The shortage of flu vaccine last year was a reminder of the importance of vaccines in health care."

Vaccine supplies to the US were severely disrupted last year, when British inspectors shut down Chiron's factory in Speke, near Liverpool, because of contamination. Chiron was to produce 50 million shots of its Fluvarin vaccine at the plant last year, and the shutdown cut the number of doses US public health officials had expected by half. Congress asked why supply depended so heavily on Chiron and one other company, and the authorities vowed to increase the number of suppliers.

The need of vaccine this year is higher than last year due to possible concerns that a particularly virulent form of avian flu could mutate and spread to the United States. Fluarix, produced by GSK and other jabs could limit the effects of a pandemic by herd vaccination; herd immunization is achieved by providing vaccination to large population of people and increasing their protection against current strains of flu and helping isolate outbreaks of avian flu.
'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. GlaxoSmithKline To Cultivate Non-Smoking Environment
3. FDA Mislead On Asthma Drug By GlaxoSmithKline
4. GlaxoSmithKline Defends Its Products
5. GlaxoSmithKline launches diabetes and cancer drugs
6. Generic Products Compete With GlaxoSmithKline
7. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
8. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
9. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
10. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
11. GlaxoSmithKline Signs Outsourcing Deal With TCS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... The ... MSC Cruises as part of the line’s 4th Annual MSC True Partnerships’ Awards. ... performing North American travel partners for the year based on overall business growth in ...
(Date:1/24/2017)... , ... January 24, 2017 , ... ... announced that it has officially formed a distribution partnership with Byers Scientific ... industrial odor management industry. , Through the agreement, OMI Industries formulated a special ...
(Date:1/24/2017)... ... January 24, 2017 , ... Providing solutions to critical ... from the Frank Hawkins Kenan Institute of Private Enterprise at the ... policy makers identified concrete solutions at the “What’s Next, America?” conference at the ...
(Date:1/24/2017)... ... January 24, 2017 , ... Date aired: January 23, ... Kleyne, the nation’s foremost water advocate and host of the nationally syndicated The ... Voice America, once again welcomed one of her favorite guests and colleagues, Dr. ...
(Date:1/24/2017)... ... ... “Speaking With God’s Voice”: a resolute and spirited call for anointed preaching ... A. Miraglia, a born-again believer, who spent his years teaching high school and Sunday-school, ... “There is little doubt that God Himself prepared me for this study, and God’s ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... NEW YORK , January 24, 2017 ... of the fastest growing industries in the United ... for medicinal use in 2016. In addition, Proposition 64, the ... 57.13% for and 42.87% against on November 8, 2016. This ... are allowed to use and to grow a certain amount ...
(Date:1/24/2017)... , January 24, 2017 ... value of USD 3.8 billion by 2025, according to ... market growth can be attributed to the rising initiatives ... early diagnosis of micro calcifications in breast tissue. Some ... CDC, and Breast Cancer Organization are promoting the early ...
(Date:1/24/2017)... -- Aptuit, LLC, hat heute den Beginn ... General Hospital (MGH) unter Leitung von Dr. Laurence ... und Validierung neuartiger Targets in gramnegativen Bakterien.  Aptuit erhofft ... Antibiotika bei der Behandlung schwerer Infektionen entgegenwirken können. ... ...
Breaking Medicine Technology: